Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E342.02 EPS (ttm)0.39 Insider Own0.06% Shs Outstand2.65B Perf Week0.60%
Market Cap349.56B Forward P/E15.45 EPS next Y8.55 Insider Trans-9.64% Shs Float2.65B Perf Month-7.07%
Income1.30B PEG44.04 EPS next Q1.99 Inst Own68.50% Short Float0.67% Perf Quarter-4.57%
Sales76.45B P/S4.57 EPS this Y8.30% Inst Trans0.94% Short Ratio2.35 Perf Half Y-0.59%
Book/sh27.56 P/B4.79 EPS next Y5.49% ROA11.00% Target Price150.86 Perf Year8.48%
Cash/sh6.13 P/C21.54 EPS next 5Y7.77% ROE22.80% 52W Range119.48 - 148.32 Perf YTD-5.51%
Dividend3.36 P/FCF39.58 EPS past 5Y11.20% ROI17.00% 52W High-10.99% Beta0.76
Dividend %2.55% Quick Ratio1.00 Sales past 5Y2.00% Gross Margin67.00% 52W Low10.50% ATR3.08
Employees126400 Current Ratio1.30 Sales Q/Q10.30% Oper. Margin26.10% RSI (14)43.94 Volatility1.93% 2.65%
OptionableYes Debt/Eq0.48 EPS Q/Q-10.40% Profit Margin21.40% Rel Volume0.66 Prev Close129.91
ShortableYes LT Debt/Eq0.36 EarningsJan 23 BMO Payout53.80% Avg Volume7.56M Price132.02
Recom2.40 SMA20-1.71% SMA50-5.25% SMA200-2.42% Volume5,029,571 Change1.62%
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
May-18-17Reiterated Stifel Hold $124 → $128
May-15-17Upgrade JP Morgan Neutral → Overweight
Jan-26-17Downgrade Wells Fargo Outperform → Market Perform
Jan-25-17Reiterated RBC Capital Mkts Outperform $133 → $128
Oct-19-16Reiterated UBS Buy $137 → $144
Feb-23-18 07:09PM  3 Big Drugmakers Boosting Huge R&D Budgets Motley Fool
02:37PM  JNJ INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Johnson & Johnson and a Lead Plaintiff Deadline of April 9, 2018 Business Wire
12:15PM  Pawar Law Group Announces That a Class Action Lawsuit Has Been Filed On Behalf of Shareholders Who Purchased Shares of Johnson & Johnson (NYSE: JNJ) Between February 22, 2013 and February 7, 2018, Both Dates Inclusive ACCESSWIRE
09:47AM  Can brands force fix of social media's problems? American City Business Journals
09:19AM  Achillion (ACHN) Q4 Loss Widens, Plans Job Cuts to Save Cost Zacks
07:17AM  3 Top Dividend Stocks With Yields Over 2% Motley Fool
Feb-22-18 07:01PM  Jim Cramer: You Have to Decide If You Want to Profit From This Moment TheStreet.com
02:15PM  JNJ SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Johnson & Johnson and a Lead Plaintiff Deadline of April 9, 2018 GlobeNewswire
01:33PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Johnson & Johnson To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
10:45AM  Why Is Johnson & Johnson (JNJ) Down 8.5% Since its Last Earnings Report? Zacks
08:02AM  February Pharma And Biotech Dividend Stocks To Look Out For Simply Wall St.
Feb-21-18 05:18PM  Why TG Therapeutics Stock Jumped 10% Today Motley Fool
04:15PM  Johnson & Johnson to start vertical construction on $18M Lake Nona facility American City Business Journals
03:27PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Johnson & Johnson of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 9, 2018 Business Wire
08:03AM  Can Johnson & Johnson Replace Remicade for $100 Million Upfront? Motley Fool
Feb-20-18 04:43PM  Johnson & Johnson to Participate in Cowen 38th Annual Healthcare Conference PR Newswire
03:19PM  JNJ INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Johnson & Johnson Investors Business Wire
02:18PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Johnson & Johnson of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 9, 2018 JNJ GlobeNewswire
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline - April 9, 2018 GlobeNewswire
08:52AM  What's in the Cards for Geron (GERN) This Earnings Season? Zacks
12:40AM  [$$] US companies might be liquidating their offshore bond hoards Financial Times
Feb-19-18 05:23PM  J&J Is Exploring a Sale of Its $2 Billion Sterilization Division Bloomberg
Feb-18-18 11:47AM  Why Healthcare Stocks Soared in Trump's First Year in Office Motley Fool
Feb-17-18 10:30AM  This Blue-Chip Healthcare Stock Deserves a Gold Medal for Its Financial Fortitude Motley Fool
Feb-16-18 05:13PM  Stocks stretch winning streak to 6 days despite turbulence Associated Press
01:15PM  The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Johnson & Johnson Business Wire
10:44AM  Coca-Cola earnings show the beverage businessnot bottlingis booming Yahoo Finance Video
10:03AM  Johnson & Johnson Consumer Presents New Scientific Research At 2018 American Academy of Dermatology Annual Meeting PR Newswire
08:04AM  Dow 30 Stock Roundup: Cisco Beats, Caterpillar January Sales up 34% Zacks
04:23AM  J&J (JNJ) Gets FDA Nod for New Prostate Cancer Treatment (Revised) Zacks
Feb-15-18 04:38PM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of Johnson & Johnson Investors (JNJ) Business Wire
01:53PM  The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Johnson & Johnson Business Wire
01:27PM  6 Healthcare Stocks We Think Deserve Gold Medals (Hint: One's a Marijuana Stock) Motley Fool
09:19AM  J&J (JNJ) Gets FDA Nod for New Prostrate Cancer Treatment Zacks
08:20AM  Todays Research Reports on Trending Tickers: Johnson & Johnson and Merck & Company ACCESSWIRE
Feb-14-18 05:46PM  FDA approves J&J prostate cancer treatment Reuters
03:35PM  ONGOING INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Johnson & Johnson ACCESSWIRE
03:07PM  Scott+Scott, Attorneys at Law, LLP Alerts Investors to the Filing of a Securities Class Action Against Johnson & Johnson (JNJ) Business Wire
02:45PM  JNJ SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Johnson & Johnson Business Wire
10:45AM  Cory Booker joins Kirsten Gillibrand and other Senate Democrats in rejecting corporate PAC donations CNBC
10:15AM  The Decline In Johnson & Johnson Could Be Close to Being Over TheStreet.com
Feb-13-18 03:08PM  Opioid Litigants Get Boost From Senate Report TheStreet.com
12:25PM  JNJ LOSS NOTICE: Rosen Law Firm Reminds Johnson & Johnson Investors of Important Deadline in First Filed Case Business Wire
11:44AM  JNJ SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Johnson & Johnson Business Wire
10:16AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline - April 9, 2018 ACCESSWIRE
08:18AM  Better Buy: Eli Lilly and Company vs. Johnson & Johnson Motley Fool
12:39AM  [$$] The Tax Law Is About to Make Analyzing Earnings Trickier The Wall Street Journal
Feb-12-18 10:36PM  Opioid makers gave $10M to advocacy groups amid epidemic Associated Press
10:26PM  Opioid makers paid millions to advocacy groups -U.S. Senate report Reuters
08:40PM  INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Johnson & Johnson ACCESSWIRE
07:30PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Johnson & Johnson (NYSE: JNJ) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
07:30PM  Opioid makers paid millions to advocacy groups -U.S. Senate report Reuters
03:27PM  Is AbbVie or Vertex Pharmaceuticals the Better Buy Now? Motley Fool
02:37PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Johnson & Johnson -- JNJ Business Wire
10:25AM  New drug promises to kill flu virus in a day American City Business Journals
06:52AM  [$$] The Tax Law Is About to Make Analyzing Earnings Trickier The Wall Street Journal
Feb-11-18 11:55PM  [$$] Experimental Drug Promises to Kill the Flu Virus in a Day The Wall Street Journal
Feb-10-18 07:26PM  SHAREHOLDER ALERT: Pawar Law Group Announces Investigation of Securities Claims Against Johnson & Johnson - JNJ ACCESSWIRE
05:36PM  OxyContin maker will stop promoting opioids to doctors Associated Press
07:35AM  What Should You Know About Johnson & Johnsons (NYSE:JNJ) Long Term Outlook? Simply Wall St.
07:00AM  [$$] Experimental Drug Promises to Kill the Flu Virus in a Day The Wall Street Journal
12:01AM  [$$] Drug Tests in South Korea Barrons.com
Feb-09-18 08:32PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Johnson & Johnson Investors (JNJ) Business Wire
02:48PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Johnson & Johnson Business Wire
11:35AM  FDA Okays J&J's Prostate Cancer Drug in First-Line Setting Zacks
11:02AM  Rosen Law Firm Files Securities Class Action Lawsuit Against Johnson & Johnson Business Wire
11:00AM  Solid Q4 Earnings Drive Pharma ETF Outlook Zacks
10:30AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline: April 9, 2018 PR Newswire
10:30AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline: April 9, 2018 CNW Group
06:02AM  3 Dividend Stocks Perfect for Retirement Motley Fool
Feb-08-18 08:54PM  JNJ INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Johnson & Johnson Investors Business Wire
04:50PM  IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Johnson & Johnson ACCESSWIRE
04:34PM  Market Correction in 2018? Hedge Funds Say You Should Own These 5 Stocks Insider Monkey
11:41AM  Johnson & Johnson to Participate in the 2018 CAGNY Conference PR Newswire
11:26AM  Theravance, J&J Ink Deal for Inflammatory Intestinal Drug Zacks
11:10AM  Novartis' Cosentyx Label Expanded to Include Scalp Psoriasis Zacks
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Johnson & Johnson (JNJ) PR Newswire
09:41AM  The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease Benzinga
08:30AM  Janssen and Johnson & Johnson to Provide Webcast Presentation on Phase 3 Data for Apalutamide and the Janssen Prostate Cancer Strategy and Portfolio PR Newswire
Feb-07-18 07:00PM  3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback TheStreet.com
06:30PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Johnson & Johnson JNJ GlobeNewswire
02:52PM  Top Defensive Consumer Stocks for 2018 Investopedia
11:45AM  Buying On Dips Is Good But This Time Investors Got Burned Investopedia
11:10AM  Why Theravance Biopharma Shares Are Soaring 24/7 Wall St.
10:58AM  Johnson & Johnson to Participate in RBC Capital Markets 2018 Global Healthcare Conference PR Newswire
Feb-06-18 06:28PM  3 Dividend Stocks That Should Pay You the Rest of Your Life Motley Fool
02:49PM  Jeff Auxier Comments on Johnson & Johnson GuruFocus.com
06:00AM  3 Great Dividend Stocks to Buy in the Broad Market Rout TheStreet.com
Feb-05-18 08:00PM  Will the Corporate Tax Cuts Lead to Bigger Share Buybacks? Motley Fool -5.29%
07:53PM  So what happens next? CNBC Videos
07:15PM  Asian markets feel the heat, where sell-off accelerating CNBC Videos
06:56PM  Cramer's sell-off strategy: Have your shopping list ready CNBC Videos
05:29PM  Here are some stocks you can buy on the dip: Technician CNBC Videos
05:05PM  The Dow just touched correction territory: Here are the stocks that led the drop CNBC
05:00PM  Early Prostate Cancer Kept at Bay in Two Studies for High-Risk Men Bloomberg
02:11PM  Health-care ETF tumbles, pressured by pharmaceutical company weakness MarketWatch
01:01PM  Johnson & Johnson falls on report that lawsuits could expose potentially damaging documents CNBC
09:33AM  3 Top Pharmaceutical Stocks to Buy Now Motley Fool
Feb-04-18 03:36PM  Why Geron Corporation Stock Ripped Higher in January Motley Fool
Feb-03-18 10:32AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising brand adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Option Exercise90.44155,34214,049,130357,906Feb 20 07:46 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale129.86155,34220,172,401202,564Feb 20 07:46 PM
Caruso Dominic JExec VP, Finance; CFOFeb 09Option Exercise0.0010,6010154,703Feb 13 06:54 PM
Duato JoaquinExec VP, WW Chair, PharmaFeb 09Option Exercise0.009,812078,348Feb 13 06:54 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 09Option Exercise0.005,830069,992Feb 13 06:54 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0033,1650285,990Feb 13 06:54 PM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 09Option Exercise0.0011,445070,205Feb 13 06:54 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 09Option Exercise0.0013,2520181,655Feb 13 06:55 PM
Ullmann Michael HExec VP, General CounselFeb 09Option Exercise0.005,9530115,257Feb 13 06:55 PM
Kapusta Ronald AController, CAOFeb 09Option Exercise0.002,702032,666Feb 13 06:55 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 02Option Exercise0.0032,688032,688Feb 06 04:21 PM
Stoffels PaulusExec VP, Chief Scientific OffOct 31Option Exercise0.0075,4920203,142Nov 02 05:01 PM
Stoffels PaulusExec VP, Chief Scientific OffJul 24Option Exercise72.54102,6927,449,278230,342Jul 26 11:49 AM
Stoffels PaulusExec VP, Chief Scientific OffJul 24Sale133.14102,69213,672,629127,650Jul 26 11:49 AM
Caruso Dominic JExec VP, Finance; CFOJul 20Option Exercise61.7582,5915,099,994226,693Jul 24 11:06 AM
Caruso Dominic JExec VP, Finance; CFOJul 20Sale136.7282,59111,291,478144,102Jul 24 11:06 AM
Duato JoaquinExec VP, WW Chair, PharmaMar 03Option Exercise59.7650,0002,987,780118,536Mar 07 04:21 PM
Duato JoaquinExec VP, WW Chair, PharmaMar 03Sale123.6250,0006,181,14068,536Mar 07 04:21 PM
Kapusta Ronald AController, CAOFeb 28Option Exercise72.5414,5431,054,94944,507Mar 02 05:50 PM
Kapusta Ronald AController, CAOFeb 28Sale122.2614,5431,777,95429,964Mar 02 05:50 PM
Pruden Gary JExec VP, WW Chair, Med DevicesFeb 28Sale122.2116,2991,991,94343,630Mar 02 05:16 PM